Methods for in vitro susceptibility testing of chlamydia
Patent 6258532 Issued on July 10, 2001. Estimated Expiration Date: 
February 18, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 18, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPermanent suspension pharmaceutical dosage form Antibacterial coated medical implants Treatment for toxoplasmosis with a composition comprising a sulfonamide and a spiropiperidyl derivative of rifamycin S. Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment Method for detection of nucleic acid targets by amplification and fluorescence polarization Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis Diagnosis and treatment of arterial chlamydial granuloma Patent #: 6043225 InventorsAssigneeApplicationNo. 025176 filed on 02/18/1998US Classes:435/6, Involving nucleic acid435/7.36, Sexually transmitted disease (e.g., chlamydia, syphilis, gonorrhea, etc.)435/23, Involving proteinase435/32, Testing for antimicrobial activity of a material435/34, Determining presence or kind of micro-organism; use of selective media435/91.2, Acellular exponential or geometric amplification (e.g., PCR, etc.)536/23.7Encodes a microbial polypeptideExaminersPrimary: Myers, Carla J.Assistant: Johannsen, Diana Attorney, Agent or FirmForeign Patent References
International ClassesC12Q 001/68C12Q 001/37 C12Q 001/18 G01N 033/571 C12P 019/34 AbstractMethods for determining the susceptibility of intracellular pathogens, particularly Chlamydia, to single or combination of test agents are described. The methods can be used for in vitro or in vivo evaluation of agents that can be used as therapeutic agents in the treatment/eradication of pathogen infection in general or to target a specific infected organ. Assays which utilize nucleic amplification techniques (e.g., PCR) to determine effectiveness of the agent(s) evaluated are also described.Other References
Field of SearchInvolving nucleic acidSexually transmitted disease (e.g., chlamydia, syphilis, gonorrhea, etc.) Testing for antimicrobial activity of a material Acellular exponential or geometric amplification (e.g., PCR, etc.) Involving proteinase Determining presence or kind of micro-organism; use of selective media Encodes a microbial polypeptide Probes for detection of microbial nucleotide sequences Primers |
| ||||||||||||||
